Published in Physician Law Weekly, October 5th, 2005
The current year results compare with prior year net earnings of $123.1 million, or $1.15 per fully diluted share, on total revenues of $1.31 billion. Adjusted net earnings for fiscal 2005 were $254.3 million, or $2.40 per fully diluted share excluding a charge of $0.37 per fully diluted share related to a potential litigation settlement and product acquisition of Organon's Mircette oral contraceptive product.
Adjusted net earnings for the fiscal year ended June 30, 2004,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly